Details
- Status
- Closed
- Reference
- HORIZON-MISS-2024-CANCER-01-03
- Publication date
- 18 April 2024
- Opening date
- Deadline model
- Single-stage
- Deadline date
- 18 September 2024, 17:00 (CEST)
- Programme Sector
- Health
- Programme
- Horizon Europe
- Horizon Europe Cluster 1: Health
- Tags
- EU financing
- EUCancerPlan
- Medical research
- Public health
Description
For an increasing number of cancers with underlying heritable genetic risk, early detection and diagnosis are possible.
HaDEA has published the call HORIZON-MISS-2024-CANCER-01, comprising six topics.
Proposals should aim to deliver results through validating, piloting, and upscaling genetic, multi-omics, or other biomarker-based tests for early detection of cancers with underlying heritable genetic risk in routine healthcare.